mynth
← DATABASE
12/2024100%

Ladr – Laboratory Group Dr. Kramer & Colleagues acquired by Sonic Healthcare

GERMANY Health Providers / Healthcare Facilities / Labs (Biology) EV €300–700M

Context

Sonic Healthcare has signed binding agreements to acquire the LADR Laboratory Group, marking a substantial expansion of its German and European diagnostic footprint. The transaction was structured on a cash and debt-free basis, with a total consideration satisfied through a mix of Sonic ordinary shares (up to 222 million euros) and cash funded from existing facilities. The strategic rationale centers on the strong cultural and operational alignment between the two organizations, with significant synergy potential identified in procurement, laboratory overlaps, logistics, and equipment maintenance. The deal also includes an inherited put/call structure for a separate German laboratory business, expected to be fully consolidated by 2027. Following the acquisition, the target's senior leadership, including the CEO and Medical Director, will remain with the group to lead the integration collaboratively with the acquirer’s German division.

Ladr – Laboratory Group Dr. Kramer & Colleagues, which reported an EBITDA margin of [members only] in 2024, is valued in this transaction at an EV/EBITDA multiple of 5x–12x.

-> Deep-dive in Healthcare & Pharma market trends

Target

LADR is one of the top five medical laboratory groups in Germany, providing high-quality diagnostic testing services through a national network of stand-alone and hospital-based laboratories. Founded in 1945 and managed by the third generation of the Kramer family, the group's business model is predominantly focused on medical laboratory revenue (80% of total), supplemented by medical supplies trading, logistical services, and a specialized clinical services division focused on women’s health. The group maintains a significant international footprint, including "badaj.to," the fourth largest laboratory group in Poland, and a joint-venture interest in Finland. Operating with over 2,800 full-time staff, LADR leverages a centralized laboratory hub in Geesthacht to provide comprehensive diagnostic solutions across the German healthcare landscape, emphasizing medical leadership and high-quality clinical outcomes.

Ent. Value

€300–700M

Equity Value

[members only]

Multiples

EV / Revenue

1x–3x

EV / EBITDA

5x–12x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2024
€250–500M
€50–100M
[members only]
2023
€250–500M
€50–100M
[members only]

Similar deals in Health Providers

Similar deals in Health Providers
DateAcquirerTargetCountrySector
05/2025FONDATION SANTE SERVICECLARIANE HAD (HOME HOSPITALIZATION SERVICES)FRANCEOutpatient Care
04/2025EUROFINS SCIENTIFICSYNLAB SPAINSPAINLabs (Biology)
12/2024CAPZAIMDEVFRANCERadiology
11/2024WELLTOWERCARE UKUNITED KINGDOMNursing Homes
11/2024GROUPE IMAGERIE CARDINETRADIOLOGIE PARIS OUESTFRANCERadiology
10/2024MONTEFIORE INVESTMENTDEMENEGOITALYOphthalmology
10/2024QUALIUMIMPC (IMAGERIE MEDICALE PARIS CENTRE)FRANCERadiology
10/2024ARDIANVISTA VISIONITALYOphthalmology
08/2024ORLANDO HEALTHBROOKWOOD BAPTIST HEALTH SERVICESUNITED STATESClinics / Hospitals
06/2024INTEGRAL DIAGNOSTICS LIMITEDCAPITOL HEALTH LIMITEDAUSTRALIARadiology

REFERENCES

Valuation range: EV €300–700M

Revenue range: €250–500M

EBITDA range: €50–100M

EV/Revenue range: 1x - 3x

EV/EBITDA range: 5x - 12x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Ladr – Laboratory Group Dr. Kramer & Colleagues by Sonic Healthcare are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers Sonic Healthcare’s acquisition of 100% of Ladr – Laboratory Group Dr. Kramer & Colleagues, a German company specialised in Healthcare Facilities, in 2024.

How was the acquisition of Ladr – Laboratory Group Dr. Kramer & Colleagues by Sonic Healthcare valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €300–700M band, its EV/EBITDA multiple within the 5x - 12x range, and its EV/revenue multiple within the 1x - 3x range. Exact figures are available to members.

What were Ladr – Laboratory Group Dr. Kramer & Colleagues’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Ladr – Laboratory Group Dr. Kramer & Colleagues generated annual revenue estimated in the €250–500M range and EBITDA in the €50–100M bracket (FY 2024). Detailed financial figures are available to members.

What sources support the information on this transaction?

Data on this transaction was compiled from the official corporate announcement published by the parties, combined with independent reporting from specialized financial and M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.